158 related articles for article (PubMed ID: 22051530)
1. How to manage essential thrombocythemia.
Finazzi G
Leukemia; 2012 May; 26(5):875-82. PubMed ID: 22051530
[TBL] [Abstract][Full Text] [Related]
2. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia.
Finazzi G; Barbui T
Leukemia; 2008 Aug; 22(8):1494-502. PubMed ID: 18596737
[TBL] [Abstract][Full Text] [Related]
3. Essential thrombocythemia.
Finazzi G; Harrison C
Semin Hematol; 2005 Oct; 42(4):230-8. PubMed ID: 16210036
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of essential thrombocythemia].
Alvarez-Larrán A; Cervantes F; Besses C
Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
[TBL] [Abstract][Full Text] [Related]
5. [Primary thrombocythemia: diagnosis and therapy].
Petrides PE
Med Klin (Munich); 2006 Aug; 101(8):624-34. PubMed ID: 16896569
[TBL] [Abstract][Full Text] [Related]
6. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
Barbui T; Finazzi G
Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889
[TBL] [Abstract][Full Text] [Related]
7. Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
Finazzi G; Barbui T
Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833
[TBL] [Abstract][Full Text] [Related]
8. Essential thrombocythemia (ET): moving from palliation to cure.
Tsimberidou AM; Giles FJ
Hematology; 2002 Dec; 7(6):315-23. PubMed ID: 12475736
[TBL] [Abstract][Full Text] [Related]
9. Update on diagnosis and management of essential thrombocythemia.
Gisslinger H
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):430-6. PubMed ID: 16810619
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with essential thrombocythemia: current concepts and perspectives.
Briere J; Guilmin F
Pathol Biol (Paris); 2001 Mar; 49(2):178-83. PubMed ID: 11317966
[TBL] [Abstract][Full Text] [Related]
11. Primary thrombocythemia: new drugs for an evolving disease.
Balduini CL
Haematologica; 1992; 77(4):297-301. PubMed ID: 1427439
[No Abstract] [Full Text] [Related]
12. Indications for lowering platelet numbers in essential thrombocythemia.
Barbui T
Semin Hematol; 2003 Jan; 40(1 Suppl 1):22-5. PubMed ID: 12682878
[TBL] [Abstract][Full Text] [Related]
13. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
Griesshammer M; Struve S; Barbui T
Blood Rev; 2008 Sep; 22(5):235-45. PubMed ID: 18617299
[TBL] [Abstract][Full Text] [Related]
14. Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis.
Samuelson B; Chai-Adisaksopha C; Garcia D
J Thromb Thrombolysis; 2015 Nov; 40(4):474-9. PubMed ID: 25894476
[TBL] [Abstract][Full Text] [Related]
15. Practical approach to treating essential thrombocythaemia: case studies.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):40-2. PubMed ID: 17727566
[No Abstract] [Full Text] [Related]
16. Anagrelide: what was new in 2004 and 2005?
Petrides PE
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):399-408. PubMed ID: 16810615
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of essential thrombocythemia.
Gangat N; Tefferi A
Expert Opin Pharmacother; 2008 Jul; 9(10):1679-85. PubMed ID: 18570601
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of essential thrombocythemia].
Costello R; O'Callaghan T; Sébahoun G
Rev Med Interne; 2005 Dec; 26(12):947-55. PubMed ID: 16122842
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of thrombocytosis in essential thrombocythaemia.
Birgegård G
Ann Hematol; 2009 Jan; 88(1):1-10. PubMed ID: 18629498
[TBL] [Abstract][Full Text] [Related]
20. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
Barbui T; Finazzi G
Curr Hematol Rep; 2003 May; 2(3):248-56. PubMed ID: 12901347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
